Nexgel (NXGL) Common Equity (2018 - 2025)

Nexgel's Common Equity history runs 8 years deep, the most recent figure standing at $4.9 million for Q4 2025.

• Quarterly Common Equity fell 19.56% year-over-year to $4.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.9 million (down 19.56% YoY) and the FY2025 annual result came in at $4.9 million, down 19.56% from the prior year.
• Common Equity was $4.9 million for Q4 2025 at Nexgel, down from $5.6 million in the prior quarter.
• Across five years, Common Equity topped out at $12.1 million in Q4 2021 and bottomed at $270000.0 in Q2 2021.
• A 5-year average of $5.8 million and a median of $5.6 million in 2025 frame the typical range for Common Equity.
• Peak annual rise in Common Equity reached 16921.13% in 2021, while the deepest fall reached 38.78% in 2021.
• Nexgel's Common Equity stood at $12.1 million in 2021, then tumbled by 36.81% to $7.6 million in 2022, then sank by 32.36% to $5.2 million in 2023, then increased by 17.69% to $6.1 million in 2024, then fell by 19.56% to $4.9 million in 2025.
• Business Quant data shows NXGL's Common Equity at $4.9 million in Q4 2025, $5.6 million in Q3 2025, and $5.1 million in Q2 2025.